Literature DB >> 302209

Cellular events in protein-tolerant inbred rats. IV. The mechanism of immunogen-maintained tolerance.

E B Bell, F L Shand, S Gradwell.   

Abstract

The ability of immunogens to maintain or extend a state of unresponsiveness was investigated in unbred rats using a human serum albumin (HSA) model of tolerance. Rats initially challenged with immunogen within two weeks of high or low dose tolerance induction by tolerogen (soluble HSA) remained hyporesponsive even a year and a half later and in some cases became less responsive following a subsequent challenge. An inhibitory effect of immunogen on escape from tolerance was formally demonstrated: in comparison with an unchallenged group, tolerant rats which received a second immunogen challenge 6 months after the first, synthesized less antibody; this antibody underwent a gradual decline in affinity after each challenge which suggested that higher avidity B cells were progressively lost. In addition, immunogen-maintained tolerant rats (a) had demonstrable helper T cell activity among their thoracic duct lymphocytes on adoptive transfer, (b) did not produce a significant increase in antibody synthesis after receiving peripheral T cells and (c) provided no evidence that suppressor cells were playing a role. The results suggested that the mechanisms of tolerance induction by tolerogen and tolerance maintenance by immunogen are fundamentally different.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 302209     DOI: 10.1002/eji.1830070615

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Prevention of tolerance in differentiating B lymphocytes by T cells.

Authors:  C J Elson
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

2.  Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin.

Authors:  R H Loblay; B Fazekas de St Groth; H Pritchard-Briscoe; A Basten
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.